MS
Michael D Step
CEODirector

Michael D Step insider trades: Ritter Pharmaceuticals (RTTR) stock buys and sales

CEO, Ritter Pharmaceuticals Last trade May 11, 2017 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2006
2
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 11, 2017RTTR↑ Buy$8K
Feb 27, 2017RTTR↑ Buy$26K
Jan 7, 2016RTTR↑ Buy$40K
Sep 5, 2013SNTS↓ Sell$702K
Jul 5, 2013SNTS↓ Sell$659K
May 6, 2013SNTS↓ Sell$568K
Mar 5, 2013SNTS↓ Sell$468K
Mar 16, 2006SNTS↑ Buy$20K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael D Step's insider trades

Michael D Step is CEO at Ritter Pharmaceuticals (RTTR). Since Mar 16, 2006, Michael has reported 4 open-market purchases worth $94K and 4 sales worth $2.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), option exercises (5 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RTTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.